ReviewDiagnostics (Basel, Switzerland)2025
Trends in Clinical Cardiac Photon-Counting Detector CT Research: A Comprehensive Bibliometric Analysis.
Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Human In Vivo Cardiac Magnetic Resonance Imaging at 7 T: Feasibility, Applications, and Current Limitations-A Systematic Review.Diagnostics (Basel, Switzerland) · 2026Review
- Applications of photon-counting CT in oncologic imaging: A systematic review.World journal of radiology · 2025Article
- Computed Tomography Advancements in Plaque Analysis: From Histology to Comprehensive Plaque Burden Assessment.Echocardiography (Mount Kisco, N.Y.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photon-counting detector computed tomography (PCD-CT) represents a significant advancement in radiological imaging, offering substantial potential for cardiac applications that remain partially underexplored. This bibliometric analysis investigates the evolution and current clinical application of cardiac PCD-CT by examining research trends from 2019 to 2024. The analysis aims to understand the development of this technology, its clinical implications, and future directions. A comprehensive literature search was conducted using databases such as PubMed, EMBASE, Scopus, and Google Scholar, yielding 984 records. After removing duplicates and applying inclusion criteria, 81 studies were included in the final analysis. These studies primarily focused on coronary artery calcium scoring, coronary atherosclerotic plaque assessment, and coronary artery stenosis quantification. The findings indicate a significant upward trend in the number of publications, peaking in 2023. The bibliometric analysis revealed that the USA, Germany, and Switzerland are the leading contributors to PCD-CT research, with prominent institutions like the Mayo Clinic and the University of Zurich driving advancements in the field. The NAEOTOM Alpha by Siemens Healthineers, being the only commercially available PCD-CT model, highlights its central role in cardiac imaging studies. Funding for PCD-CT research came from various sources, including industry leaders like Siemens and Bayer, as well as governmental and academic institutions. The analysis also identified several challenges that PCD-CT research faces, including the need for larger patient cohorts and broader geographical representation. In conclusion, the rapid growth of cardiac PCD-CT research underscores its transformative potential in clinical practice. Continued investment, collaboration, and extensive research are essential to fully harness the benefits of PCD-CT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.